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Abstract
Maintenance of a balance between commensal bacteria and the mucosal immune system
is crucial and intestinal dysbiosis may be a key event in the pathogenesis of colorectal can-
cer (CRC). The toll-like receptor 4 (TLR4) is an important pattern-recognition receptor that
regulates inflammation and barrier function in the gut by a mechanism that involves activa-
tion of the nuclear factor–κB (NF-κB) transcription factor. Dietary and life style factors may
impact these functions. We therefore used a Danish prospective case-cohort study of 1010
CRC cases and 1829 randomly selected participants from the Danish Diet, Cancer and
Health cohort to investigate three polymorphisms in NFKB1 and TLR4 and their possible in-
teractions with diet and life style factors in relation to risk of CRC. Homozygous carriage of
the variant allele of the TLR4/rs5030728 polymorphism was associated with increased risk
of CRC (incidence rate ratio (IRR) = 1.30; 95% confidence interval (CI): 1.05–1.60; P = 0.02
(gene-dose model); IRR = 1.24; 95%CI: 1.01–1.51; P = 0.04 (recessive model)). Del-carri-
ers of the NFKB1/rs28362491 polymorphism had a 17% (95%CI: 1.03–1.34; P = 0.02) in-
creased risk of CRC compared to homozygous carriers of the ins-allele. However, none of
these risk estimates withstood adjustment for multiple comparisons. We found no strong
gene-environment interactions between the examined polymorphism and diet and life style
factors in relation to CRC risk.
Introduction
Colorectal cancer (CRC) is the third most common cancer type in men and the second in
women worldwide [1]. Hereditary factors are estimated to contribute to only 35% of the risk
[2] emphasizing the importance of environmental factors in the etiology of CRC. Indeed,
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dietary and lifestyle factors have been intensively studied for their role in colorectal carcinogen-
esis; and alcohol, smoking, obesity and high meat intake are now established risk factors for
CRC [3–5]. Intake of red and processed meat has the potential of inducing cancer by chemical
carcinogens formed during cooking of meat at high temperatures [6], production of toxic fer-
mentation compounds [7–9] or by inducing inflammation due to changes in bacterial compo-
sition [10]. Conversely, fibre, fruit and vegetables provide short-chain fatty acids (SCFAs) to
the colonic epithelium by fermentation of unabsorbed dietary fibre and starch [11–15]. The
SCFA butyrate is important for colonic integrity [14], inhibits growth of cancer cells in vitro
[16,17] and has anti-inflammatory properties mainly by the inhibition of nuclear factor—κB
(NF-κB) activation [18].
Toll-like receptors (TLR) are important pattern-recognition receptors that regulate inflam-
mation and barrier function in the gut thereby maintaining a balance between commensal bac-
teria and the mucosal immune system [19,20]. The receptor for gram-negative bacterial
lipopolysaccharide (LPS), TLR4, regulates cell proliferation in response to cell injury through
induction of cyclooxygenase 2 expression [21] in a cascade that involves activation of NF-κB
and epidermal growth factor [22] suggesting that TLR4 is an important element in the transi-
tion from inflammation to neoplasia [19]. Indeed, increased expression of TLR4 has been
linked to development of inflammation-associated neoplasia [23–26]. In addition, we have pre-
viously found evidence that inflammation may contribute to CRC carcinogenesis. Thus, geneti-
cally determined high IL-1β and COX-2 levels were associated with increased risk of CRC [27].
Dysbiosis in the gut may be a key event in the pathogenesis of both inflammatory bowel dis-
eases (IBD) and CRC. Using functional single nucleotide polymorphisms (SNPs) and their in-
teraction with diet and life style may reveal important pathways for colorectal carcinogenesis
[28]. Since TLR polymorphisms have been associated with IBD [29], we aimed to examine a
possible mutual mechanism for IBD and CRC.
We have previously shown that carriage of the variant del-allele of the functional ins/del
NFKB1/rs28362491 polymorphism is associated with increased risk of CRC and interacted with
meat intake in a subset of the current study group [30] in agreement with results from two
other studies also reporting increased risk of CRC among variant carriers of the polymorphism
among a Malaysian [31] and a Swedish population [32], but not a Chinese study group [32]. A
functional SNP in TLR4 (rs4986790) has been extensively studied and has been associated with
neoplastic progression in vitro [33], aggressive human colon cancer [33], IBD [34–37] and CRC
[38–40]. However others were not able to find an association between CRC and the SNP [41–
43]. In a Canadian study [44], intake of dietary saturated fatty acids was inversely related to
blood level of high density lipoprotein cholesterol in individuals homozygous for the TLR4/
rs5030728 G-allele. TLR4/rs5030728 may therefore interact with dietary components in the gut.
Thus, we expected that inflammation is an important factor in colorectal carcinogenesis and
thus examined whether diet and life style factors (non-steroidal anti-inflammatory drugs
(NSAID) and smoking) modify CRC risk by altering the mucosal immune response in the gut
via interacting with TLR4 and NF-κB. We therefore evaluated three polymorphisms in NFKB1
and TLR4 and their possible interaction with diet and life style factors in a prospective cohort
of 1010 CRC cases and 1829 randomly selected participants from the Danish Diet, Cancer and
Health Study.
Material and Methods
Studied subjects
The Diet, Cancer and Health study is an ongoing Danish cohort study designed to investigate
the relation between diet, lifestyle and cancer risk [45]. The cohort consists of 57,053 persons,
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recruited between December 1993 and May 1997. All the subjects were born in Denmark, and
the individuals were 50 to 64 years of age and had no previous cancers at study entry. Blood
samples and questionnaire data on diet and lifestyle were collected at study entry.
Follow-up and endpoints
Follow-up was based on population-based cancer registries. Between 1994 and 31th December
2009, 1010 CRC cases were diagnosed. A sub-cohort of 1829 persons was randomly selected
within the cohort. 28 persons were both cases and sub-cohort due to the used study design
[46]. 245 with missing genotype data and 16 with missing data on risk factors were excluded.
All information on genotypes and diet and lifestyle factors was available for 915 CRC cases and
1719 sub-cohort members.
Dietary and lifestyle questionnaire
Information on diet, lifestyle, weight, height, medical treatment, environmental exposures, and
other socio-economic factors were collected at enrolment using questionnaires and interviews
and has been described in details elsewhere [27,47–49]. In short, the food-frequency question-
naire, diet consumption was assessed in 12 categories of predefined responses, ranking from
‘never’ to ‘eight times or more per day’. The daily intake was then calculated by FoodCalc [45].
Smoking status was classified as never, past or current. Persons smoking at least 1 cigarette daily
during the last year were classified as smokers. NSAID use (“Aspirin”, “Paracetamol”, “Ibupro-
fen”, or “Other pain relievers) was assessed as 2 pills per month during one year at baseline.
Genotyping
Buffy coat preparations were stored at minus 150°C until use. DNA was extracted as described
[50]. The DNA was genotyped by LGC KBioscience (LGC KBioscience, Hoddesdon, United
Kingdom) by PCR-based KASP genotyping assay (Error! Hyperlink reference not valid. www.
lgcgenomics.com/). NFKB1/rs28362491 was analysed and reported for a subset of the current
study group [30]. Two of the polymorphisms (NFKB1/rs28362491 and TLR4/rs4986790) were
chosen based on known functionality and their association with CRC [30–33] and IBD [34–37]
from a literature search. The TLR4/rs5030728 polymorphism, on the other hand, has no known
functionality. However, TLR4/rs4986790 is tightly linked with TLR4/rs5030728 (D’: 1.0; r2:
0.017) using Haploview version 4.2 (Broad Institute of MIT and Harvard, Cambridge) [51]
with HapMap3 Genome Browser release #2 (Phase 3) [52]; and since TLR4/rs5030728 has a
higher minor allele frequency in Caucasians than TLR4/rs4986790 (0.305 vs. 0.035), this poly-
morphism is more suitable for gene-environment interaction analyses. To confirm reproduc-
ibility, genotyping was repeated for 10% of the samples yielding 100% identity.
Statistical analysis
Deviation from Hardy-Weinberg equilibrium was assessed using a Chi-square test.
Incidence rate ratios (IRR) and 95% Confidence Interval (CI) were calculated according to
the principles for analysis of case-cohort studies using an un-weighted approach [46]. Age was
used as the time scale in the Cox regression models. Tests and confidence intervals were based
onWald’s tests using the robust estimate of the variance-covariance matrix for the regression
parameters in the Cox regression models [53] as previously described [27,46,48,54–61].
All models were adjusted for baseline values of risk factors for colorectal cancer such as
body mass index (BMI) (kg/m2, continuous), use of hormone replacement therapy (HRT)
(never/past/current, among women), intake of dietary fibre (g/day, continuous), and red meat
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and processed meat (g/day, continuous) and in addition to suspected risk factors such as
NSAID use (yes/no) and smoking status (never/past/current). Cereals, fibre, fruit and vegeta-
bles were also entered linearly. All analyses were stratified by gender, so that the basic (underly-
ing) hazards were gender specific. For all the polymorphisms, IRR was calculated separately for
heterozygous and homozygous variant allele carriers. For TLR4/rs4986790 and NFKB1/
rs28362491, variant allele carriers were subsequently grouped for interaction analyses since no
recessive effects were observed. TLR4/rs5030728 was inferred both in a gene-dose and a reces-
sive mode in the subsequent analyses.
Moreover, we assessed weekly use of NSAID based on the results of a study of colorectal
cancer within the Diet, Cancer and Health cohort [62] reporting that long-term consistent use
of Aspirin or Non-Aspirin NSAID appears necessary to achieve a protective effect. However,
there were no differences in risk estimates between monthly or weekly use, consequently, to
maintain the statistical power in the strata; we used monthly NSAID use in the analyses.
The likelihood ratio test was used for interaction analyses between the studied polymor-
phisms and intake of red and processed meat, dietary fibre, cereals, fish, fruits, vegetables, alco-
hol intake, smoking status and NSAID use. In interaction analyses where the dietary factors
were entered as categorical variables, tertile cutpoints were based on the empirical distribution
among male and female cases, respectively. The possible interactions were investigated using
the likelihood ratio test.
All analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC). A p<0.05
was considered to be significant. Moreover, to test for multiple comparisons, Bonferroni cor-
rection was used.
Ethics statement
All participants gave verbal and written informed consent. The Diet, Cancer and Health study
was approved by the National Committee on Health Research Ethics (journal nr. (KF) 01–345/
93) and the Danish Data Protection Agency.
Results
Baseline characteristics of the study population are presented in Table 1. Among sub-cohort
members, the genotype distribution of the SNPs did not deviate from Hardy-Weinberg equilib-
rium (results not shown).
Associations between polymorphisms and CRC
Homozygous variant carriers of the TLR4/rs5030728 polymorphism were at 1.30-fold (95%CI:
1.05–1.60) increased risk of CRC in a gene-dose model and at 1.24-fold (95%CI: 1.01–1.51) in-
creased risk of CRC compared to wild type and heterozygous carriers in a recessive model
(Table 2). Moreover, carriers of theNFKB1 del-allele had a 17% (95%CI: 1.03–1.34) increased
risk of CRC compared to homozygous carriers of the ins-allele (Table 2). These risk estimates
did not, however, reach statistically significance after Bonferroni correction. There was no inter-
action between the two risk genotypes TLR4/rs5030728 andNFKB1/rs28362491 but on the other
hand, there was no additive effect of being homozygous carrier of both variant alleles (S1 Table).
Gene-environment analyses
We found no interaction between any of the dietary factors and the studied polymorphisms in
relation to risk of CRC in the linear analyses (S2 Table). In the tertile analyses, there was weak
interaction between TLR4/rs5030728 and intake of vegetables (Gene-dose model: P-value for
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interaction (Pint) = 0.05; Recessive model: Pint = 0.03) (Table 3). Moreover, a borderline statisti-
cally significant interaction between meat intake and the NFKB1/rs28362491 polymorphism
(Pint = 0.06) was found (Table 3). For ins-carriers, risk estimates were comparable across ter-
tiles of meat intake. Conversely, among del-carriers, intake of meat in the second (IRR = 1.46;
95%CI: 1.17–1.83) and third tertile (IRR = 1.24; 95%CI: 0.99–1.56) was associated with risk of
CRC, whereas del-allele carriers were not at risk in the first tertile with low meat intake (IRR =
0.98; 95%CI: 0.78–1.23). With regard to alcohol, variant carriers of NFKB1/rs28362491 and ho-
mozygous A-allele carriers of TLR4/rs5030728 were associated with CRC risk compared to the
homozygous wild type carriers among participants with a low intake of alcohol. Furthermore,
for variant carriers of all three polymorphisms, a low intake (first tertile) of alcohol was associ-
ated with the highest CRC risk compared with moderate (second tertile) intake—which was as-
sociated with the lowest risk—and high alcohol intake (third tertile) (Table 3).
There was no interaction between NSAID use or smoking status and the studied genotypes
(S3 and S4 Tables). Among non-smokers (S4 Table), however, the TLR4/rs5030728
Table 1. Baseline characteristics of the study participants by selected demographic and established CRC risk factors.
Variable Cases Sub-cohort IRRa (95% CI)
n (%) Median (5–95%) n (%) Median (5–95%)
Total 915 (100) 1719 (100)
Sex
Men 515 (56) 920 (54)
Women 400 (44) 799 (46)
Age at inclusion (years) 58 (51–64) 56 (50–64)
BMI (kg/m2) 26.3 (20.7–34.3) 25.6 (20.5–33.0) 1.03 (1.00–1.06)d
Food intake (g/day)
Alcoholb 15.1 (1.0–71.6) 14.2 (1.2–65.3) 1.03 (1.00–1.07)e
Dietary ﬁbre 19.9 (10.8–32.9) 20.7 (10.7–34.2) 0.88 (0.80–0.97)f
Red and processed meat 113.1 (47.4–233.4) 108.9 (41.5–235.4) 1.03 (1.00–1.06)g
Smoking status
Never 274 (30) 572 (33) 1.00 (ref.)
Past 280 (31) 513 (30) 1.04 (0.88–1.23)
Current 361 (39) 634 (37) 1.11 (0.94–1.30)
NSAID usec
No 632 (69) 1174 (68) 1.00 (ref.)
Yes 283 (31) 545 (32) 0.99 (0.86–1.14)
HRT use among women
Never 246 (62) 418 (52) 1.00 (ref.)
Past 50 (13) 126 (16) 0.66 (0.49–0.90)
Current 104 (26) 255 (32) 0.74 (0.59–0.93)
Values are expressed as medians (5th and 95th percentiles) or as fractions (%).
aIRRs for CRC—mutually adjusted.
bAmong current drinkers.
cNSAID use is deﬁned as  2 pills per month during one year.
dRisk estimate per 2 kg/m2 increment of BMI.
eRisk estimate for the increment of 10 g alcohol per day.
fRisk estimate for the increment of 10 g dietary ﬁbres per day.
gRisk estimate for the increment of 25 g red and processed meat per day.
doi:10.1371/journal.pone.0116394.t001
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polymorphism demonstrated gene-dose effect which is comparable with the results seen
among participants with low intake of alcohol (Table 3). In a model where the risk of CRC was
inferred per 25 g intake of meat per day subdivided by NSAID use, the risk of CRC by meat in-
take increased in a dose-dependent manner among variant allele carriers of TLR4/rs5030728 in
the absence of NSAID use, but not among NSAID-users (S5 Table). Thus, meat intake was not
associated with risk among homozygous carriers of the wild type allele, whereas meat intake
was associated with a 4% increased risk per 25 g meat/day (95%CI: 1.00–1.09) among heterozy-
gotes and 11% increased risk among homozygous variant allele carriers (95%CI: 1.02–1.22).
However, there were no statistically significant interactions (S5 Table).
Discussion
In the present study, we found that homozygous variant carriage of TLR4/rs5030728 and vari-
ant carriage of the NFKB1/rs28362491 polymorphism were associated with increased risk of
CRC, but not after correction for multiple testing. We only found weak interactions with a few
dietary factors and, thus, we were not able to reproduce the previously found interaction be-
tween the NFKB1/rs28362491 polymorphism and meat intake. The lack of association between
TLR4/rs4986790 and CRC found in the present study could possibly be due to the very low var-
iant allele frequency in the Danish population. Only one person was homozygous variant allele
carrier. We therefore cannot exclude that the functional effect of this SNP affects
colorectal carcinogenesis.
The NFKB1/rs28362491 polymorphism has rather consistently been associated with CRC
risk [30–32], and to some extend also IBD [29,63,64]. As previously described [65,66], NFKB1
encodes the p50/p105 subunits of the transcription factor NF-κB. NF-κB consists of homo- or
Table 2. IRR for CRC in relation to the studied polymorphisms.
ncases (%) nsub-cohort (%) IRR
a (95% CI) IRRb (95% CI) P-valuec
TLR4 rs4986790
AA 839 (92) 1577 (92) 1.00 (ref.) 1.00 (ref.) -
GA 76 (8) 141 (8) 0.99 (0.79–1.25) 1.00 (0.79–1.26) 0.98
GG 0 (0) 1 (0) - - -
GA+GG 76 (8) 142 (8) 0.99 (0.79–1.25) 1.00 (0.79–1.26) 0.97
rs5030728
GG 405 (44) 826 (48) 1.00 (ref.) 1.00 (ref.) -
GA 399 (44) 731 (43) 1.10 (0.96–1.26) 1.11 (0.96–1.27) 0.16
AA 111 (12) 162 (9) 1.30 (1.06–1.61) 1.30 (1.05–1.60) 0.02
GA+AA 510 (56) 398 (23) 1.14 (1.00–1.30) 1.14 (1.00–1.30) 0.05
AA vs. GG+GA 111 (12) 162 (9) 1.24 (1.02–1.52) 1.24 (1.01–1.51) 0.04
NFKB1 rs28362491
Ins/Ins 320 (35) 679 (60) 1.00 (ref.) 1.00 (ref.) -
Ins/Del 449 (49) 787 (46) 1.19 (1.03–1.37) 1.19 (1.03–1.37) 0.02
Del/Del 146 (16) 253 (15) 1.13 (0.93–1.37) 1.14 (0.94–1.38) 0.18
Ins/Del+Del/Del 595 (65) 1040 (61) 1.17 (1.02–1.34) 1.17 (1.03–1.34) 0.02
a Crude—adjusted for age and sex.
b In addition, adjusted for smoking status, alcohol intake, HRT status (women only), BMI, use of NSAID, intake of red and processed meat, and
dietary ﬁbre.
c P-value for the adjusted estimates.
doi:10.1371/journal.pone.0116394.t002
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heterodimers of a number of different subunits p65, p50, p105, C-rel and relB [67,68] and the
combination determines target gene specificity. As a p65/p50 heterodimer, the complex is pro-
inflammatory [68], whereas the p50 homodimer has anti-inflammatory properties
[65,67,69,70]. The relative abundance of p50/p65 heterodimers and p50 homodimers will
therefore determine the magnitude of inflammation by balancing the pro-inflammatory and
anti-inflammatory response [67]. The NFKB1/rs28362491 polymorphism generates a deletion
of four nucleotides in the promoter region causing lowered transcription levels and conse-
quently partial depletion of p50 [63]. In agreement with this, it was found that the mRNA levels
of NFKB1 were lower in colon biopsies of healthy tissue from homozygous del-carriers com-
pared to heterozygotes [71]. This disfavours the anti-inflammatory response since the forma-
tion of the pro-inflammatory p65/p50 heterodimer depends on the concentration of p50,
whereas the formation of the anti-inflammatory p50 homodimer depends on the concentration
of p50 squared [65].
The TLR4/rs5030728 polymorphism has not yet been linked to CRC [20] and its function is
unknown [72]. TLR4/rs4986790, which has been associated with IBD and CRC, is tightly
linked with TLR4/rs5030728. It is therefore not clear which of the two polymorphisms is the bi-
ologically relevant one. However, our results indicate that carriage of TLR4/rs4986790 was not
associated with risk of CRC, whereas carriage of TLR4/rs5030728 was associated with risk. This
suggests that the risk conferred by TLR4/rs5030728 carriage was not caused by linkage with
TLR4/rs4986790. Interestingly, variant carriage of the TLR4/rs5030728 A-allele has been asso-
ciated with beneficial response to anti-TNF therapy among patients with IBD [73], implying
that these patients may have a higher baseline activity or expression of TLR4.
The two TLR4 SNP are present on several commonly used GWAS arrays (https://www.
broadinstitute.org/mpg/snap/ldsearch.php) whereas the ins/del NFKB1/rs28362491 polymor-
phism is not monitored linkage in GWAS [65]. None of the two TLR4 SNPs were associated
with CRC in GWAS. However, our main focus was to search for gene-environment interac-
tions, rather than identifying loci with strong associations to CRC. Gene-environment interac-
tions are rarely assessed in GWAS.
We did not find any strong indications of gene-environment interactions. For variant carri-
ers of NFKB1/rs28362491 and homozygous A-allele carriers of TLR4/rs5030728, risk of CRC
among low meat consumers was lower compared to medium and high meat consumers, who
had risk estimates between 1.24 and 1.70 indicating a stronger role of meat in colorectal carci-
nogenesis among subjects with genetically determined high inflammatory response. Alterna-
tively, meat intake covaries with other life style factors that per se induce an inflammatory
response that we have not been able to adjust for.
The found interaction with vegetables and TLR4/rs5030728 in the present study is not di-
rectly interpretable and could be due to small groups in the tertiles. However, vegetables
seemed to slightly increase the risk of CRC in the present study, which should be addressed in
other prospective studies.
We had limited statistical power to detect gene-environment interactions. However, the
prospective study design used in this study is well suited for gene-environment interaction
analyses due to the collection of dietary and life style factors before diagnosis, eliminating the
risk of recall bias. Changing in dietary and life style habits during follow-up is, however, possi-
ble, but is not expected to result in differential misclassification between cases and the compari-
son group. In addition, the present study group is homogenous consisting of Danes and two of
the studied polymorphisms have high allele frequencies. Using the present study group, we
have previously found gene-environment interactions between diet and IL10 rs3024505 (Pint;
meat = 0.04, fish = 0.007, fibre = 0.0008, vegetables = 0.0005), IL1B C-3737T (Pint; NSAID
use = 0.040), PTGS2 G-765C (Pint; meat = 0.006, fibre = 0.0003, fruit 0.004), and PTGS2
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T8473C (Pint; fruit = 0.03) and PTGS2 A-1195G (Pint;fibre 0.020 and current smoking = 0.046)
[27]. We adjusted risk estimates for suspected risk factors and carefully selected the polymor-
phisms based on function and/or previously findings on association with dietary factors, CRC
or IBD. However, none of the analyses withstood adjusting for multiple testing. Thus, we can-
not rule out that our findings are due to chance and they should therefore not be considered as
significant associations.
In conclusion, this study was not able to demonstrate associations between the studied poly-
morphisms in the inflammatory mediator genes NFKB1 and TLR4 as none of the found associ-
ations withstood adjustment for multiple comparisons. We found no strong gene-environment
interactions between the examined polymorphisms and diet and life style factors in relation to
CRC risk.
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